Finance

Beta
Lists
ALB:BMV
Albemarle Corp
MX$2,929.00
+1.63%
(+47.00) 1D
Jun 3, 11:41:57 AM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for ALB...
Open
MX$2,970.00
High
MX$2,970.00
Low
MX$2,929.00
Mkt. cap
19.99B
Avg. vol.
78.00
Volume
11.00
52-wk high
MX$3,675.00
52-wk low
MX$1,080.00
Shares outstanding
106.21M
No. of employees
8K
Open
MX$2,970.00
High
MX$2,970.00
Low
MX$2,929.00
Mkt. cap
19.99B
Avg. vol.
78.00
Volume
11.00
52-wk high
MX$3,675.00
52-wk low
MX$1,080.00
Shares outstanding
106.21M
No. of employees
8K
News stories
From sources across the web
Profile
Albemarle Corporation is an American specialty chemicals manufacturing company based in Charlotte, North Carolina. It serves several different industries including Agriculture/Food, Automotive/EV, Aviation/Aerospace, Building/Construction, Conventional Energy, Electronics, Grid Storage, and Industrial Processes. The company reported over $5.4 Billion in revenue in 2024. As of April 2025, Albemarle was the fourth highest grossing producer of Lithium, falling behind Rio Tinto, Sociedad Química y Minera, and Ganfeng Lithium. Albemarle is a large developer of flame retardant chemicals technologies, with production plants in the United States, China, the Netherlands, Belgium, Germany, France, Austria, and the United Kingdom. It also has a line of antioxidants and blends which concentrate on improving storage life and stability of fuel and other lubricant products. It produces products used in rigid and flexible polyurethane foam applications and ammonium polyphosphate products, pigments for paper applications, aluminium oxides used for flame-retardant, polishing, catalyst, and niche ceramic applications, as well as magnesium hydroxide mainly used as a flame-retardant. Wikipedia
About Albemarle Corp
CEOJ Kent Masters
Employees7.8K
FoundedFeb 28, 1994
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.33B
1.31B
1.43B
1.43B
Cost of goods sold
1.13B
1.19B
1.23B
927.76M
Cost of revenue
1.13B
1.19B
1.23B
927.76M
Research and development expenses
12.44M
12.67M
12.18M
9.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
129.24M
133.78M
158.24M
137.67M
Operating expense
141.69M
146.46M
170.42M
146.84M
Total operating expenses
1.27B
1.34B
1.40B
1.07B
Operating income
55.19M
-28.84M
32.31M
354.13M
Other non operating income
-90.93M
39.88M
179.27M
76.45M
EBT including unusual items
69.29M
-178.51M
-244.43M
350.49M
EBT excluding unusual items
115.02M
1.54M
37.70M
465.38M
Income tax expense
34.09M
-30.56M
157.33M
21.51M
Effective tax rate
49.21%
17.12%
-64.37%
6.14%
Other operating expenses
-
-
-
-
Net income
22.90M
-160.69M
-414.18M
319.09M
Net profit margin
1.72%
-12.29%
-29.00%
22.33%
Earnings per share
0.11
-0.19
-0.53
2.95
Interest and investment income
10.10M
-
-
-
Interest expense
-49.94M
-50.96M
-50.30M
-45.71M
Net interest expenses
-39.84M
-50.96M
-50.30M
-45.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
223.92M
135.64M
196.02M
511.94M
Gain or loss from assets sale
-
-
-
95.02M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more